HCW Biologics Ownership | Who Owns HCW Biologics?

HCW Biologics Ownership Summary

HCW Biologics is owned by 3.26% institutional investors, 52.30% insiders, and 44.44% retail investors. Avantax planning partners is the largest institutional shareholder, holding 0.75% of HCWB shares. Fidelity Extended Market Index is the top mutual fund, with 0.26% of its assets in HCW Biologics shares.

HCWB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	HCW Biologics	3.26%	52.30%	44.44%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Avantax planning partners	279.54K	0.75%	$180.86K
Hightower advisors	180.81K	0.49%	$117.00K
Geode capital management	170.38K	0.46%	$110.27K
Cresset asset management	131.99K	0.35%	$85.40K
Pullen investment management	85.12K	0.23%	$55.07K
Bridgeway capital management	84.70K	0.23%	$54.80K
Hrt financial lp	66.66K	0.18%	$43.00K
Blackrock	42.66K	0.11%	$27.60K
Vanguard group	37.68K	0.10%	$24.38K
Ae wealth management	30.00K	0.08%	$19.41K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Pullen investment management	85.12K	0.05%	$55.07K
Avantax planning partners	279.54K	0.01%	$180.86K
Bridgeway capital management	84.70K	0.00%	$54.80K
Cresset asset management	131.99K	0.00%	$85.40K
Ae wealth management	30.00K	0.00%	$19.41K
Hrt financial lp	66.66K	0.00%	$43.00K
Hightower advisors	180.81K	0.00%	$117.00K
Tower research capital llc (trc)	6.21K	0.00%	$4.02K
Ubs group	4.29K	-	$2.77K
Citadel advisors	13.88K	-	$8.98K

Top Buyers

Holder	Shares	% Assets	Change
Avantax planning partners	279.54K	0.01%	99.76K
Citadel advisors	13.88K	-	13.88K
Ubs group	4.29K	-	3.68K
Tower research capital llc (trc)	6.21K	0.00%	1.27K
Hightower advisors	180.81K	0.00%	1.00K

Top Sellers

Holder	Shares	% Assets	Change
Jane street group	-	-	-24.14K
Hrt financial lp	66.66K	0.00%	-6.45K
Geode capital management	170.38K	-	-3.90K
Blackrock	42.66K	-	-3.37K
Bank of america corp /de/	156.00	-	-250.00

Sold Out

Holder	Change
Jpmorgan chase	-9.00
Wells fargo & company/mn	-141.00
Jane street group	-24.14K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	18	-5.26%	1,212,337	10.20%	3	34.74%	7	-	5	-
Mar 31, 2024	19	5.56%	1,100,110	3.30%	3	34.85%	7	-36.36%	5	66.67%
Dec 31, 2023	18	28.57%	1,064,955	4.94%	2	37.12%	11	83.33%	3	50.00%
Sep 30, 2023	14	16.67%	1,014,821	1.46%	2	36.37%	6	20.00%	2	-
Jun 30, 2023	12	-7.69%	1,000,256	14.36%	2	46.92%	5	-	2	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	97.34K	0.26%	-2.38K
Bridgeway Ultra-Small Company Market	84.70K	0.22%	-
iShares Micro-Cap ETF	40.69K	0.11%	-
Vanguard Institutional Extnd Mkt Idx Tr	37.68K	0.10%	-
Fidelity Total Market Index	29.02K	0.08%	-
Fidelity Nasdaq Composite Index	23.27K	0.06%	-
Fidelity Series Total Market Index	22.60K	0.06%	14.85K
NT Ext Equity Mkt Idx Fd - L	9.06K	0.02%	-
Northern Trust Extended Eq Market Idx	9.06K	0.02%	-
Spartan Extended Market Index Pool E	7.30K	0.02%	401.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 14, 2023	Wong Hing C	Chief Executive Officer	Buy	$3.74K
Sep 14, 2023	Winer Gary M	-	Buy	$336.96
Sep 13, 2023	Winer Gary M	-	Buy	$92.00
Sep 13, 2023	Winer Gary M	-	Buy	$1.02K
Sep 14, 2023	Winer Gary M	-	Buy	$1.80K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	16	-
2023 Q2	17	-
2022 Q4	-	-

HCWB Ownership FAQ

Who Owns HCW Biologics?

HCW Biologics shareholders are primarily institutional investors at 3.26%, followed by 52.30% insiders and 44.44% retail investors. The average institutional ownership in HCW Biologics's industry, Biotech Stocks , is 44.97%, which HCW Biologics falls below.

Who owns the most shares of HCW Biologics?

HCW Biologics’s largest shareholders are Avantax planning partners (279.54K shares, 0.75%), Hightower advisors (180.81K shares, 0.49%), and Geode capital management (170.38K shares, 0.46%). Together, they hold 1.69% of HCW Biologics’s total shares outstanding.

Does Blackrock own HCW Biologics?

Yes, BlackRock owns 0.11% of HCW Biologics, totaling 42.66K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 27.6K$. In the last quarter, BlackRock decreased its holdings by -3.372K shares, a -7.33% change.

Who is HCW Biologics’s biggest shareholder by percentage of total assets invested?

Pullen investment management is HCW Biologics’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 85.12K HCW Biologics shares, valued at 55.07K$.

Who is the top mutual fund holder of HCW Biologics shares?

Fidelity Extended Market Index is the top mutual fund holder of HCW Biologics shares, with 0.26% of its total shares outstanding invested in 97.34K HCW Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools